Drug
Mrtx0902
Mrtx0902: highest development phase Phase 1, developed by Mirati Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Mirati Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| MRTX0902 NCT05578092 | Phase 1 | Solid Tumor |
Latest
No recent events.
Follow Mrtx0902 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.